May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Giulio Francolini: QoL data from DART trial
May 4, 2025, 12:33

Giulio Francolini: QoL data from DART trial

Giulio Francolini, Radiation Oncologist at Careggi University Hospital, shared a post on X:

“QoL data from DART trial (SBRT+/- darolutamide in oligorec. pCa).

Global health and most QoL subdomains remained stable in both arms over the 24-week period.

More fatigue and hormonal treatment-related symptoms were observed in the SBRT and DARO arm, ESTRO.”

The post presents updated findings from the DART trial, indicating stable quality of life across both study arms over 24 weeks.

However, patients receiving both SBRT and darolutamide experienced increased fatigue and hormonal symptoms.

Giulio Francolini: QoL data from DART trial

More posts featuring ESTRO on OncoDaily.